A Randomized Clinical Trial of Adipose-derived Stem Cells in Treatment of Non Revascularizable Ischemic Myocardium

Key Inclusion Criteria: * Able to provide written informed consent * Males or females 20 to 75 years of age, inclusive * Coronary artery disease not amenable to any type of revascularization procedure (percutaneous or surgical) in the target area * Hemodynamic stability * Ability to undergo liposuction * Ability to walk on a treadmill * Negative urine pregnancy test (females only). Key Exclusion Criteria: * Unstable angina * Serum creatinine \>2.5 mg/dL * Planned or scheduled staged treatment of CAD or other interventional or surgical procedures * Cardiogenic shock * History of resuscitated sudden cardiac death; or symptomatic or sustained ventricular fibrillation or ventricular tachycardia. * Vascular anatomy that precludes cardiac catheterization * Peripheral artery disease that precludes insertion of an 8 Fr sheath * Severe valvular disease * Pregnant or nursing females * Known and relevant allergies or sensitivities * Life expectancy \<1 year * Participation in any other clinical research study that has not reached its primary endpoint or otherwise would interfere with the subject's participation in this study * Any concurrent disease or condition that, in the opinion of the investigator, would make the subject unsuitable for participation in the study.